Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | clozapine | 135398737 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | clozapine | 135398737 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | clozapine | 135398737 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | clozapine | 135398737 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | betazole | 188803 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | betazole | 188803 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | haloperidol | 3559 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | haloperidol | 3559 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | haloperidol | 3559 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | haloperidol | 3559 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | haloperidol | 3559 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | haloperidol | 3559 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | haloperidol | 3559 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | haloperidol | 3559 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | haloperidol | 3559 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | haloperidol | 3559 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | haloperidol | 3559 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | haloperidol | 3559 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | haloperidol | 3559 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | haloperidol | 3559 | drug-path |